TRPC6 and autism spectrum disorder: TRPC6 variants (i.e., loss-of-function mutations) are candidate risk genes for Autism Spectrum Disorder (ASD) [83]; TRPC6-mediate neuronal SOCE has been demonstrated in a human iPS model to be crucial in counteracting neuronal hyperexcitability in ASD [84].